“Intravitreal Sirolimus For The Treatment Of Geographic Atrophy: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 56. Invest Ophthalmol Vis Sci: 330-338. http://www.ncbi.nlm.nih.gov/pubmed/25525171.
. 2015. “Treatment Of Geographic Atrophy With Subconjunctival Sirolimus: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 54. Invest Ophthalmol Vis Sci: 2941-2950. http://www.ncbi.nlm.nih.gov/pubmed/23548622.
. 2013. . 2010.
“Treatment Of Geographic Atrophy By The Topical Administration Of Ot-551: Results Of A Phase Ii Clinical Trial”. Invest Ophthlmol Vis Sci 51. Invest Ophthlmol Vis Sci: 613-619. http://www.ncbi.nlm.nih.gov/pubmed/20574018.
. 2010. “High-Dose Daclizumab For The Treatment Of Juvenile Idiopathic Arthritis-Associated Active Anterior Uveitis”. Am J Ophthalmol 148. Am J Ophthalmol: 696-703.e1. http://www.ncbi.nlm.nih.gov/pubmed?term=19664754.
. 2009. “Infliximab For The Treatment Of Active Scleritis”. Can J Ophthalmol 44. Can J Ophthalmol: e9-e12. http://www.ncbi.nlm.nih.gov/pubmed/19506593.
. 2009. “Electronic Data Acquisition”. In Society For Clinical Trials. Society For Clinical Trials. St. Louis MO.
. 2008. “Intravitreal Ranibizumab For Treatment Of Retinal Capillary Hemangioblastoma (Rch) Related To Von-Hippel Lindau (Vhl) Disease”. In Association For Research In Vision And Ophthalmology (Arvo). Association For Research In Vision And Ophthalmology (Arvo). Ft. Lauderdale, FL.
. 2008. “Intravitreal Ranibizumab Therapy For Retinal Capillary Hemangioblastoma Related To Von Hippel-Lindau Disease”. Ophthalmology 115. Ophthalmology: 1957-1964. http://www.ncbi.nlm.nih.gov/pubmed/18789534.
. 2008.